GOLDEN: Efficacy and Safety of Complement Factor B Antisense, Sefaxersen, in Geographic Atrophy due to Age-Related Macular Degeneration.
- DOI
- 10.1016/j.xops.2026.101340
- Published
- 2026 Oct
- Container
- Ophthalmology science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xops.2026.101340,
title = {GOLDEN: Efficacy and Safety of Complement Factor B Antisense, Sefaxersen, in Geographic Atrophy due to Age-Related Macular Degeneration.},
author = {Jaffe GJ and Wykoff CC and McCaleb ML and Barrett TD and Frazer-Abel A and Norris D and Luhmann UFO and Cukras C and Yin L and Lomax M and Fauser S and Schneider E and Brice GT and GOLDEN Investigators},
year = {2026},
journal = {Ophthalmology science},
doi = {10.1016/j.xops.2026.101340},
url = {https://doi.org/10.1016/j.xops.2026.101340}
}RIS
TY - JOUR TI - GOLDEN: Efficacy and Safety of Complement Factor B Antisense, Sefaxersen, in Geographic Atrophy due to Age-Related Macular Degeneration. AU - Jaffe GJ AU - Wykoff CC AU - McCaleb ML AU - Barrett TD AU - Frazer-Abel A AU - Norris D AU - Luhmann UFO AU - Cukras C AU - Yin L AU - Lomax M AU - Fauser S AU - Schneider E AU - Brice GT AU - GOLDEN Investigators PY - 2026 JO - Ophthalmology science DO - 10.1016/j.xops.2026.101340 UR - https://doi.org/10.1016/j.xops.2026.101340 ER -
APA
GJ, J., CC, W., ML, M., TD, B., A, F., D, N., UFO, L., C, C., L, Y., M, L., S, F., E, S., GT, B., & Investigators, G. (2026). GOLDEN: Efficacy and Safety of Complement Factor B Antisense, Sefaxersen, in Geographic Atrophy due to Age-Related Macular Degeneration.. Ophthalmology science. https://doi.org/10.1016/j.xops.2026.101340
Source records
- pubmed · retrieved 2026-09-27T08:51:10.493Z